An additional ORF coding for a replication mechanism can be added to a...

An additional ORF coding for a replication mechanism can be added to a...

wikipedia - 25 Aug 2021
An additional ORF coding for a replication mechanism can be added to amplify antigen translation and therefore immune response, decreasing the amount of starting material needed.[11][12]

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

Reuters - 25 Apr 2024
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology ...

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

Nature.com - 18 Apr 2024
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial ...

Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer - On Cancer

Memorial Sloan Kettering - 07 Apr 2024
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer ...

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program

AccessWire - 25 Apr 2024
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program ...

Vaccine breakthrough means no more chasing strains | UCR News | UC Riverside

UC Riverside - 15 Apr 2024
Vaccine breakthrough means no more chasing strains | UCR News | UC Riverside ...

BioNTech mRNA Vaccine Manufacturing Facility, Rwanda

Pharmaceutical Technology - 24 Apr 2024
BioNTech mRNA Vaccine Manufacturing Facility, Rwanda ...

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

WHBL - 25 Apr 2024
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology ...

World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas

Clinical Trials Arena - 24 Apr 2024
World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas ...

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

Yahoo Finance Australia - 25 Apr 2024
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology ...

RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified

Medscape - 07 Feb 2024
RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified ...

The WHO's Push for Global mRNA Vaccine Access

Think Global Health - 26 Feb 2024
The WHO's Push for Global mRNA Vaccine Access ...

mRNA Vaccines: What to Know

IDSA - 04 Mar 2024
mRNA Vaccines: What to Know ...

MIT engineers design more powerful RNA vaccines | MIT News | Massachusetts Institute of Technology

MIT News - 07 Sep 2023
MIT engineers design more powerful RNA vaccines | MIT News | Massachusetts Institute of Technology ...

How Penn Medicine is changing the world with mRNA | Penn Today

Penn Today - 08 Jan 2024
How Penn Medicine is changing the world with mRNA | Penn Today ...

China's drugmakers can't sell mRNA shots but haven't quit yet

Reuters - 19 Apr 2024
China's drugmakers can't sell mRNA shots but haven't quit yet ...

An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation

Nature.com - 20 Apr 2024
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation ...

Sanofi signs mRNA vaccine development deal with IDT Australia

Pharmaceutical Technology - 18 Apr 2024
Sanofi signs mRNA vaccine development deal with IDT Australia ...

Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA ...

Nature.com - 18 Apr 2024
Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA ... ...

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211 ...

Nature.com - 23 Oct 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211 ... ...

RNA vaccine